Format

Send to

Choose Destination
Curr Psychiatry Rep. 2014 Dec;16(12):527. doi: 10.1007/s11920-014-0527-z.

Proceed with caution: off-label ketamine treatment for major depressive disorder.

Author information

1
Department of Medical Ethics & Health Policy, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA, sistid@mail.med.upenn.edu.

Abstract

Ketamine offers a promising new option for the treatment of depression, but its increasing off-label use is ethically and clinically inappropriate at the moment.

PMID:
25308395
DOI:
10.1007/s11920-014-0527-z
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Springer
Loading ...
Support Center